3D 바이오프린팅 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The 3D Bioprinting Market size is expected to reach USD 10.87 Billion in 2034 from USD 3.69 Billion (2025) growing at a CAGR of 12.76% during 2026-2034.

The global 3D bioprinting market is gaining momentum due to advancements in biotechnology and regenerative medicine. This technology enables the creation of complex biological structures using living cells, offering significant potential in tissue engineering and drug testing. Increasing investments in research and development are driving innovation and expanding the applications of 3D bioprinting across healthcare sectors.

Major growth drivers include the rising demand for organ transplants and the shortage of donor organs. Bioprinting offers a promising solution by enabling the development of artificial tissues and organs. Additionally, pharmaceutical companies are adopting this technology for drug discovery and testing, reducing the need for animal trials and improving efficiency.

Looking ahead, the market is expected to experience rapid growth as technology continues to evolve. Collaboration between research institutions and industry players will further accelerate development. As regulatory frameworks become more supportive, 3D bioprinting is likely to revolutionize personalized medicine and transform the future of healthcare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Magnetic Levitation
• Inkjet-Based
• Syringe-Based
• Laser-Based
• Others

By Application

• Medical
• Dental
• Biosensors
• Consumer / Personal Product Testing
• Bioinks
• Food and Animal Product

COMPANIES PROFILED

• EnvisionTEC Inc, Organovo Holdings Inc now VivoSim Labs Inc, Inventia Life Science Pty Ltd, Poietis, Vivax Bio LLC, Allevi, Cyfuse Biomedical KK, 3D Bioprinting Solutions, Cellink formerly Cellink Global, Regemat 3D SL
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL 3D BIOPRINTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Magnetic Levitation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Inkjet-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Syringe-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Laser-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL 3D BIOPRINTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Medical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Dental Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Biosensors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Consumer / Personal Product Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Bioinks Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Food and Animal Product Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL 3D BIOPRINTING MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Technology
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Technology
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Technology
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Technology
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Technology
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL 3D BIOPRINTING INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 EnvisionTEC Inc
  • 8.2.2 Organovo Holdings Inc. (now VivoSim Labs Inc.)
  • 8.2.3 Inventia Life Science Pty Ltd
  • 8.2.4 Poietis
  • 8.2.5 Vivax Bio LLC
  • 8.2.6 Allevi
  • 8.2.7 Cyfuse Biomedical K.K
  • 8.2.8 3D Bioprinting Solutions
  • 8.2.9 Cellink (formerly Cellink Global)
  • 8.2.10 Regemat 3D S.L